THOR is a targetable epigenetic biomarker with clinical implications in breast cancer.
Apolónio JD, Dias JS, Fernandes MT, Komosa M, Lipman T, Zhang CH, Leão R, Lee D, Nunes NM, Maia AT, Morera JL, Vicioso L, Tabori U, Castelo-Branco P.
Apolónio JD, et al. Among authors: dias js.
Clin Epigenetics. 2022 Dec 18;14(1):178. doi: 10.1186/s13148-022-01396-3.
Clin Epigenetics. 2022.
PMID: 36529814
Free PMC article.